Medical Xpress·4 min read·hard
Keeping HIV at bay: New approach explores broadly neutralizing antibodies to treat infants
✦AI Summary
Researchers have conducted a clinical trial showing that infants can tolerate treatment with broadly neutralizing antibodies to combat HIV. This approach aims to address the challenge of viral reservoirs that make curing HIV in children difficult.
Why it matters
This medical advancement offers a potential new strategy for treating pediatric HIV, which currently requires lifelong antiretroviral therapy.
edited by Gaby Clark , reviewed by Robert Egan
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article reports on scientific research findings published in a peer-reviewed journal.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in